— Know what they know.
Not Investment Advice

APLIF OTC

Appili Therapeutics Inc
1W: -22.2% 1M: +0.0% 3M: -34.5% YTD: -53.3% 1Y: -50.0% 3Y: -82.5% 5Y: -98.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 42 · $926563 mcap · 98M float · 0.021% daily turnover · Short 53% of daily vol

Balance Sheet Trends

Total Assets
$2M -34.8% ▼
5Y CAGR: -29.3%
Total Liabilities
$19M +17.8% ▲
5Y CAGR: +52.7%
Shareholders Equity
-$17M -29.7% ▼
Cash & Investments
$40K -96.7% ▼
5Y CAGR: -67.2%
Total Debt
$13M +5.5% ▲
5Y CAGR: +66.8%
Net Debt
$13M +16.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$11M$7M$94K$1M$40K
Short-Term Investments$5M$0$0$0$0
Cash & ST Investments$16M$7M$94K$1M$40K
Net Receivables$0$421K$0$2M$2M
Inventory$267K-$48K$0$0$0
Other Current Assets$0$0$0$0$121K
Total Current Assets$18M$8M$1M$3M$2M
Property, Plant & Equip.$55K$42K$30K$19K$11K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$55K$42K$30K$19K$11K
Total Assets$18M$8M$1M$3M$2M
— Liabilities —
Accounts Payable$6M$3M$4M$4M$6M
Short-Term Debt$96K$113K$7M$12M$12M
Deferred Revenue-$118K$0$0$0$0
Other Current Liabilities-$2M-$76K$47K$0$178K
Total Current Liabilities$5M$7M$12M$16M$19M
Long-Term Debt$947K$5M$875K$736K$673K
Other Non-Current Liab.$4M$3M$0$0$0
Total Non-Current Liabilities$947K$5M$875K$736K$673K
Total Liabilities$6M$12M$12M$16M$19M
— Equity —
Common Stock$35M$40M$42M$42M$43M
Retained Earnings-$31M-$56M-$69M-$72M-$76M
Accumulated OCI$8M$9M$0$0$653K
Total Stockholders Equity$13M-$3M-$11M-$13M-$17M
Total Liabilities & Equity$18M$8M$1M$3M$2M
— Key Metrics —
Total Debt$1M$5M$8M$12M$13M
Net Debt-$10M-$2M$8M$11M$13M
Total Investments$5M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms